Search research articles
Contact Us
Filters
Showing results (171-180 of 265) with videos related to
Page
of 27
Sort By:
The Journal of Rheumatology
|
June 1, 1976
Septic arthritis in patients with rheumatoid disease: a still underdiagnosed complication
W S Mitchell, P M Brooks, R D Stevenson, et al.
Rheumatology (Oxford, England)
|
June 23, 1999
Risk taking in patients with rheumatoid arthritis: are the risks of haemopoietic stem cell transplantation acceptable?
J A Snowden, I Nivison-Smith, J C Biggs, et al.
Australian and New Zealand Journal of Medicine
|
December 1, 1995
Hazards of low dose methotrexate
P G Conaghan, D I Quinn, P M Brooks, et al.
British Journal of Rheumatology
|
April 1, 1991
Is diet important in rheumatoid arthritis?
H M Buchanan, S J Preston, P M Brooks, et al.
Annals of the Rheumatic Diseases
|
October 1, 1975
Proceedings: Raised plasma kininogen levels in rheumatoid arthritis. Response to indomethacin and relationship to clinical indices
J N Sharma, I J Zeitlin, P M Brooks, et al.
Agents and Actions
|
March 1, 1993
Third World conference on variability in response to anti-rheumatic drugs, Singapore, July 22-24, 1992
R O Day, P M Brooks, K M Williams, et al.
British Medical Journal
|
September 6, 1975
Bran in hypertriglyceridaemia: a failure of response
W F Bremner, P M Brooks, J L Third, et al.
Clinical and Experimental Immunology
|
June 1, 1990
Cytokine regulation of human monocyte interleukin-1 (IL-1) production in vitro. Enhancement of IL-1 production by interferon (IFN) gamma, tumour necrosis factor-alpha, IL-2 and IL-1, and inhibition by IFN-alpha
V A Danis, A J Kulesz, D S Nelson, et al.
Advances in Experimental Medicine and Biology
|
January 1, 1976
Raised plasma kininogen levels in rheumatoid patients-response to therapy with monsteroidal anti-inflammatory drugs
I J Zeitlin, J N Sharma, P M Brooks, et al.
Drugs
|
December 1, 1988
Variability in response to NSAIDs. Fact or fiction?
R O Day, G G Graham, K M Williams, et al.
Page
of 27
Search research articles
Search
Showing results (171-180 of 265) with videos related to
Sort By:
Page
of 27
The Journal of Rheumatology
|
June 1, 1976
Septic arthritis in patients with rheumatoid disease: a still underdiagnosed complication
W S Mitchell, P M Brooks, R D Stevenson, et al.
Rheumatology (Oxford, England)
|
June 23, 1999
Risk taking in patients with rheumatoid arthritis: are the risks of haemopoietic stem cell transplantation acceptable?
J A Snowden, I Nivison-Smith, J C Biggs, et al.
Australian and New Zealand Journal of Medicine
|
December 1, 1995
Hazards of low dose methotrexate
P G Conaghan, D I Quinn, P M Brooks, et al.
British Journal of Rheumatology
|
April 1, 1991
Is diet important in rheumatoid arthritis?
H M Buchanan, S J Preston, P M Brooks, et al.
Annals of the Rheumatic Diseases
|
October 1, 1975
Proceedings: Raised plasma kininogen levels in rheumatoid arthritis. Response to indomethacin and relationship to clinical indices
J N Sharma, I J Zeitlin, P M Brooks, et al.
Agents and Actions
|
March 1, 1993
Third World conference on variability in response to anti-rheumatic drugs, Singapore, July 22-24, 1992
R O Day, P M Brooks, K M Williams, et al.
British Medical Journal
|
September 6, 1975
Bran in hypertriglyceridaemia: a failure of response
W F Bremner, P M Brooks, J L Third, et al.
Clinical and Experimental Immunology
|
June 1, 1990
Cytokine regulation of human monocyte interleukin-1 (IL-1) production in vitro. Enhancement of IL-1 production by interferon (IFN) gamma, tumour necrosis factor-alpha, IL-2 and IL-1, and inhibition by IFN-alpha
V A Danis, A J Kulesz, D S Nelson, et al.
Advances in Experimental Medicine and Biology
|
January 1, 1976
Raised plasma kininogen levels in rheumatoid patients-response to therapy with monsteroidal anti-inflammatory drugs
I J Zeitlin, J N Sharma, P M Brooks, et al.
Drugs
|
December 1, 1988
Variability in response to NSAIDs. Fact or fiction?
R O Day, G G Graham, K M Williams, et al.
Page
of 27